Edap Tms SA

EDAP TMS S.A. announced the successful closing of its underwritten public offering of American Depositary Shares (ADSs), including the full exercise of an option to purchase additional shares, resulting in approximately $5.6 million in net proceeds.

EDAP TMS S.A. announced the pricing of an underwritten public offering of 8,425,000 American Depositary Shares (ADSs) at $4.75 per ADS, expecting to raise approximately $37.1 million in net proceeds.

FocalTherics announced preliminary Q2 2026 financial results showing significant revenue growth and progress in expanding its Focal One platform into BPH and endometriosis indications.

EDAP TMS shareholders approved all director re-elections, financial statements, and updated corporate bylaws at the 2026 Annual General Meeting.

EDAP TMS S.A. announced its rebranding to FocalTherics, a new ticker symbol FOCL, and a strategic shift to focus exclusively on high-growth robotic focal therapy by classifying legacy segments as discontinued operations.

EDAP TMS SA announced strong first quarter 2026 financial results, driven by a significant 78% year-over-year increase in High-Intensity Focused Ultrasound (HIFU) revenue, reaching $11.6 million.

EDAP TMS S.A. reported a 1.6% increase in total revenues to $70.5 million in 2025, driven by strong HIFU growth, while facing a net loss of $29.2 million and strategic shifts away from legacy businesses.

David R. Horn, a Director of Edap Tms Sa, purchased 10,000 shares of common stock on August 14, 2026 for $4.75 per share.

Fran Schulz, a Director of Edap Tms Sa, purchased 10,000 shares of common stock on August 14, 2026 for $4.75 per share.

Joshua Levine, a Director of Edap Tms Sa, purchased 10,000 shares of common stock on August 14, 2026 for $4.75 per share.

Kenneth S. Mobeck, Chief Financial Officer of Edap Tms Sa, purchased 5,000 shares of common stock on August 14, 2026 for $4.75 per share.

Lance Willsey, a Director of Edap Tms Sa, purchased 50,000 shares of common stock on August 14, 2026 for $4.75 per share.

Ryan Rhodes, Chief Executive Officer and a Director of Edap Tms Sa, purchased 21,000 shares of common stock on August 14, 2026 for $4.75 per share.

EDAP TMS S.A. has announced its 2026 Annual Combined General Meeting of Shareholders, set for June 26, 2026, to vote on director elections, financial statements, executive compensation, and strategic capital authorizations.